It has been two years since the outbreak of coronavirus disease 2019 (COVID-19). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified as the cause of the pandemic and has only gotten more complex for scientists to study. Studies of
Monkeypox Virus: A breakthrough in Scientific News – ProSci Inc
Monkeypox’s genetic code is similar to smallpox so known vaccines & anti-viral treatments are effective in reducing its spread & physiological effects.
Highly Contagious Influenza Virus – ProSci Inc.
As of May 2022, a highly contagious influenza virus continues to wreak havoc on domestic bird flocks across the United States. Millions of chickens and other fowl are dying or being killed to stop the spread of an HPAI (highly
An Alternative Supply of Lonza Classical Cell Culture Media – BioConcept
Lonza have decided to discontinue their broad range of BioWhittaker™ classical media and buffers in Europe, effective January 2022. If you are affected by this change and are looking for an alternative supplier, we can help. Caltag Medsystems have partnered
CRISPR/Cas9 technology by OZ Biosciences
“Genome editing” or “Genome engineering” gives the ability to introduce a variety of genetic alterations (deletion, insertion…) into mammalians cells. During the past decade, zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) were the tools of choice for
CELLvo Cells from StemBioSys
CELLvo™ cells from StemBioSys are the only cells isolated and expanded using StemBioSys’s CELLvo™ Matrix technology. By isolating cells on a cell-derived extracellular matrix (ECM), StemBiosys are able to preserve more natural phenotypes. Cells are always isolated from the best
Lipofection
Lipofection is a lipid-based transfection technology which belongs to biochemical methods also including polymers, DEAE dextran and calcium phosphate.
Human Cord Blood and Primary Cells
Caltag Medsystems are the European distributor of StemExpress, a leading supplier of human cord blood and cord blood primary cells. Currently, there are over 200 clinical trials worldwide investigating the use of cord blood stem cells in regenerative therapy. Cord
A seamless transition from LAB to CLINICAL TRIALS
CELLnTEC’s Higher Certified (HC) products Higher Certified (HC) culture media by CELLnTEC are used in translational bench-to-bedside research projects. They enable a seamless transition from the development of cell-based therapies into clinical trials. HC culture media are manufactured using upgraded
Human MHC Class II QuickSwitch™ Platform is used to Identify SARS-CoV-2 Virus Derived Peptides
In a previous blog post (How to screen SARS-CoV-2 peptides to facilitate T cell research) MBL International described how the immune system samples all of the pathogenic proteins by looking at the small fragments of each protein and determining whether that